Lucid Diagnostics Inc. Accounts Payable and Other Accrued Liabilities, Current
Lucid Diagnostics Inc. (LUCD) had Accounts Payable and Other Accrued Liabilities, Current of $2.72 million as of 2025-12-31, per its 10-K filed 2026-03-25.
Financial Statements › Notes › Payables and Accruals
us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent · last filed 2026-03-25
- 2025-12-31: Accounts Payable and Other Accrued Liabilities, Current $2.72M.
- 2025-09-30: Accounts Payable and Other Accrued Liabilities, Current $2.28M.
- 2025-06-30: Accounts Payable and Other Accrued Liabilities, Current $2.42M.
- 2025-03-31: Accounts Payable and Other Accrued Liabilities, Current $2.07M.
| Period end | Accounts Payable and Other Accrued Liabilities, Current |
|---|---|
| 2025-12-31 | $2.72M 10-K · filed 2026-03-25 |
| 2025-09-30 | $2.28M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $2.42M 10-Q · filed 2025-08-12 |
| 2025-03-31 | $2.07M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $2.83M 10-K · filed 2026-03-25 |
| 2024-09-30 | $2.01M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $2.73M 10-Q · filed 2024-08-12 |
| 2024-03-31 | $3.14M 10-Q · filed 2024-05-13 |
| 2023-12-31 | $3.84M 10-K · filed 2025-03-24 |
| 2023-09-30 | $3.33M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $2.64M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $2.19M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $1.45M 10-K · filed 2024-03-25 |
| 2022-09-30 | $1.13M 10-Q · filed 2022-11-14 |
| 2021-12-31 | $1.11M 10-K · filed 2023-03-14 |
| 2020-12-31 | $394.00K 10-K · filed 2022-04-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |